Merck Noxafil Powdermix (posaconazole) recalled for potential metal particulates
Merck has recalled specific lots of Noxafil Powdermix, a prescription antifungal medication, because some packets may contain metal particles. This affects 845 kits distributed nationwide. No injuries have been reported.
From the FDA notice · Read the official notice ↗
What to do
- Check if you have Noxafil Powdermix lot Z012339, Z010344, Z009908, or Z009909 with expiration date 12-31-2026
- Do not use the product if you have one of these lots
- Contact your pharmacy or doctor for a replacement or alternative medication
- Return the recalled product to your pharmacy
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC, Rahway, NJ 07056 USA, Manufactured by: N.V. Organon, 5349 AB Oss, The Netherlands, a subsidiary of Organon & Co., Jersey City, NJ 07302, USA NDC 0085-2224-02.
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
This recall covers 2 products — see all of them.
Details
- Units affected
- 845 kits
- Illnesses reported
- None reported
- Manufactured in
- 4633 Merck Rd W, N/A, Wilson, NC, United States
- Classification
- Class II
- Recall number
- D-0242-2026
In the FDA's words
- Description
- Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC, Rahway, NJ 07056 USA, Manufactured by: N.V. Organon, 5349 AB Oss, The Netherlands, a subsidiary of Organon & Co., Jersey City, NJ 07302, USA NDC 0085-2224-02. Presence of particulate matter: potential presence of metal particulates in the product. Lot#: Z012339, Z010344, Z009908, Z009909, Exp Date 12-31-2026 Distribution: Nationwide in the USA Affected quantity: 845 kits
- Hazard
- Presence of particulate matter: potential presence of metal particulates in the product.
2 products in this recall
Merck Emend and Noxafil Powdermix recalled for metal particulates
Merck is recalling two prescription medicines, Emend (aprepitant) for oral suspension 125 mg single-dose kits and Noxafil Powdermix (posaconazole) 300 mg packets, because they may contain metal particles. The recall covers 3 Emend kits and 845 Noxafil Powdermix kits, distributed nationwide. No injuries have been reported.
The agency lists each product separately. Check every one you might have.
- Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactur…D-0241-2026 · 3 - single dose kits
- Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC, Rahw… (this page)D-0242-2026 · 845 kits